Metts, J., Bradley, H. L., Wang, Z., Shah, N. P., Kapur, R., Arbiser, J. L., & Bunting, K. D. (2017). Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells. Nature Portfolio.
Chicago Style (17th ed.) CitationMetts, Jonathan, Heath L. Bradley, Zhengqi Wang, Neil P. Shah, Reuben Kapur, Jack L. Arbiser, and Kevin D. Bunting. Imipramine Blue Sensitively and Selectively Targets FLT3-ITD Positive Acute Myeloid Leukemia Cells. Nature Portfolio, 2017.
MLA (8th ed.) CitationMetts, Jonathan, et al. Imipramine Blue Sensitively and Selectively Targets FLT3-ITD Positive Acute Myeloid Leukemia Cells. Nature Portfolio, 2017.
Warning: These citations may not always be 100% accurate.